Back

Mackenzie Financial Corporation - Vivoryon Therapeutics AG - Halle

Below you will find information from the register substantial holdings and gross short positions. The information has been provided by the organisation.

  • Date of transaction 27 may 2019
  • Person obliged to notify Mackenzie Financial Corporation
  • Issuing institution Vivoryon Therapeutics AG
  • Place of residence Halle

Distribution in numbers

Type of share Number of shares Number of voting rights Capital interest Voting rights Manner of disposal Settlement
Gewoon aandeel Number of shares 401.946,00 Number of voting rights 401.946,00 Capital interest Reëel Voting rights Reëel Manner of disposal Middellijk
(Mackenzie Investments Europe Limited)
Settlement Fysieke levering

Distribution in percentages

Type Total holding Directly real Directly potential Indirectly real Indirectly potential
Kapitaalbelang Total holding 3,27 % Directly real 0,00 % Directly potential 0,00 % Indirectly real 3,27 % Indirectly potential 0,00 %
Stemrecht Total holding 3,27 % Directly real 0,00 % Directly potential 0,00 % Indirectly real 3,27 % Indirectly potential 0,00 %

Date last update: 26 June 2019

Share information

Share on: Share this